학술논문
Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia
Document Type
Article
Author
Source
In Blood 5 October 2017 130(14):1620-1627
Subject
Language
ISSN
0006-4971